Artificial intelligence and improvement of stem cell delivery in healthcare

Artificial intelligence (AI) is critical for improving the quality of stem cell manufacturing and delivery. AI can assist in determining the viability, effectiveness, efficacy, and safety of stem cells. Furthermore, in stem cell and regenerative medicine, AI is utilized to streamline simulation and model-building processes and find connections between cellular activities and their microenvironments. However, thoughtful consideration is required to minimize unwanted implications of AI incorporation for stem cell-based treatment.

REFERENCES (12)

Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: Past, present, and future. Stem Cell Res Ther. 2019;10:68. https://doi.org/10.1186/s13287... PMid:30808416.

CrossRef

Pubmed

Google Scholar

Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Futur Healthc J. 2019;6:94-8. https://doi.org/10.7861/future... PMid:31363513.

CrossRef

Pubmed

Google Scholar

Srinivasan M, Thangaraj SR, Ramasubramanian K, Thangaraj PP, Ramasubramanian KV. Exploring the Current Trends of Artificial Intelligence in Stem Cell Therapy: A Systematic Review. Cureus. 2021;13:1-14. https://doi.org/10.7759/cureus... PMid:34873560.

CrossRef

Pubmed

Google Scholar

Ramakrishna RR, Abd Hamid Z, Wan Zaki WMD, Huddin AB, Mathialagan R. Stem cell imaging through convolutional neural networks: current issues and future directions in artificial intelligence technology. PeerJ. 2020;8:e10346. https://doi.org/10.7717/peerj.... PMid: 33240655.

CrossRef

Pubmed

Google Scholar

Al-Kharusi G, Dunne NJ, Little S, Levingstone TJ. The Role of Machine Learning and Design of Experiments in the Advancement of Biomaterial and Tissue Engineering Research. Bioengineering. 2022;9:561. https://doi.org/10.3390/bioeng... PMid:36290529.

CrossRef

Pubmed

Google Scholar

Joy DA, Libby ARG, McDevitt TC. Deep neural net tracking of human pluripotent stem cells reveals intrinsic behaviors directing morphogenesis. Stem Cell Reports. 2021;16: 1317-30. https://doi.org/10.1016/j.stem... PMid:33979602.

CrossRef

Pubmed

Google Scholar

Mota SM, Rogers RE, Haskell AW, McNeill EP, Kaunas R, Gregory CA, et al. Automated mesenchymal stem cell segmentation and machine learning-based phenotype classification using morphometric and textural analysis. J Med Imaging. 2021;8:1-20. https://doi.org/10.1117/1.jmi.... PMid:33542945.

CrossRef

Pubmed

Google Scholar

Coronnello C, Francipane MG. Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning. Stem Cell Rev Reports. 2022;18:559-69. https://doi.org/10.1007/s12015... PMid:34843066.

CrossRef

Pubmed

Google Scholar

Sebastian S. Implementing robotics and artificial intelligence. Elife. 2022;11:e80609. https://doi.org/10.7554/elife.... PMid:35856938.

CrossRef

Pubmed

Google Scholar

10.

Doulgkeroglou M-N, Di Nubila A, Niessing B, König N, et al. Automation, Monitoring, and Standardization of Cell Product Manufacturing. Front Bioeng Biotechnol. 2020;8:811. https://doi.org/10.3389/fbioe.... PMid:32766229.

CrossRef

Pubmed

Google Scholar

11.

Baxi V, Edwards R, Montalto M, Saha S. Digital pathology and artificial intelligence in translational medicine and clinical practice. Mod Pathol. 2022;35:23-32. https://doi.org/10.1038/s41379... PMid:34611303.

CrossRef

Pubmed

Google Scholar

12.

Orita K, Sawada K, Koyama R, Ikegaya Y. Deep learning-based quality control of cultured human-induced pluripotent stem cell-derived cardiomyocytes. J Pharmacol Sci. 2019;140:313-6. https://doi.org/10.1016/j.jphs... PMid:31113731.